Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R V Bowman

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|June 2, 1997
Recent advances in managing non-small-cell lung cancer: 5. Endobronchial palliative therapyR V Bowman
The Medical Journal of Australia|June 19, 1995
CorticosteroidsR V Jackson, R V Bowman
Australian and New Zealand Journal of Medicine|February 1, 1985
A case of herpes zoster associated encephalitis treated with acyclovirR V Bowman, D A Lythall, C N de Wytt
Cancer Chemotherapy and Pharmacology|January 1, 1991
Chemosensitivity and cytokine sensitivity of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
The American Review of Respiratory Disease|June 1, 1989
Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cellsL S Manning, R V Bowman, S B Darby, et al.
Clinical Immunology and Immunopathology|January 1, 1991
Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
Internal Medicine Journal|November 10, 2015
A survey of lung cancer in rural and remote Aboriginal and Torres Strait Islander communities in Queensland: health views that impact on early diagnosis and treatmentB J Page, R V Bowman, I A Yang, et al.
Respiratory Medicine|June 16, 2005
Cochrane systematic reviews of treatments for lung cancerK M Fong, I A Yang, P V Zimmerman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2008
Systematic review of multidisciplinary teams in the management of lung cancerM Coory, P Gkolia, I A Yang, et al.
Cancer|May 15, 1991
Interaction between dactinomycin and tumor necrosis factor in mesothelioma. Cachexia without oncolysisR V Bowman, D Whitaker, L S Manning, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|June 2, 1997
Recent advances in managing non-small-cell lung cancer: 5. Endobronchial palliative therapyR V Bowman
The Medical Journal of Australia|June 19, 1995
CorticosteroidsR V Jackson, R V Bowman
Australian and New Zealand Journal of Medicine|February 1, 1985
A case of herpes zoster associated encephalitis treated with acyclovirR V Bowman, D A Lythall, C N de Wytt
Cancer Chemotherapy and Pharmacology|January 1, 1991
Chemosensitivity and cytokine sensitivity of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
The American Review of Respiratory Disease|June 1, 1989
Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cellsL S Manning, R V Bowman, S B Darby, et al.
Clinical Immunology and Immunopathology|January 1, 1991
Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesotheliomaR V Bowman, L S Manning, M R Davis, et al.
Internal Medicine Journal|November 10, 2015
A survey of lung cancer in rural and remote Aboriginal and Torres Strait Islander communities in Queensland: health views that impact on early diagnosis and treatmentB J Page, R V Bowman, I A Yang, et al.
Respiratory Medicine|June 16, 2005
Cochrane systematic reviews of treatments for lung cancerK M Fong, I A Yang, P V Zimmerman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2008
Systematic review of multidisciplinary teams in the management of lung cancerM Coory, P Gkolia, I A Yang, et al.
Cancer|May 15, 1991
Interaction between dactinomycin and tumor necrosis factor in mesothelioma. Cachexia without oncolysisR V Bowman, D Whitaker, L S Manning, et al.
Pageof 2